Neoadjuvant chemotherapy in stage X ovarian carcinoma

Gynecologic Oncology

Volumn 37, Issue 3, 1990, Pages 327-331

  Chambers, Joseph T ^a   Chambers, Setsuko K ^a   Voynick, Irene M ^b   Schwartz, Peter E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; TAMOXIFEN;

ARTICLE; CYTOLOGY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMAN; NEOPLASM STAGING; OVARIAN NEOPLASMS; PLATINUM; SURVIVAL ANALYSIS;

EID: 0025314435     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(90)90361-N     Document Type: Article

References (18)

1. Role of Cytoreductive surgical treatment in the management of advanced ovarian cancer
2. Review of ovarian cancer at the University of Texas System's Cancer Center, M. D. Anderson Hospital and Tumor Institute
3. Primary cytoreductive surgery for epithelial ovarian cancer
4. Stage III epithelial ovarian cancer: The role of maximal surgical reduction
5. Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma
6. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO stages III and IV) as measured by surgical endstaging (second-look operation)
7. Prognostic implications of large volume residual disease in patients with advanced stage epithelial ovarian cancer
8. Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer: A prospective randomized trial
9. Nonparametric estimation from incomplete observations
10. A generalized Kruskal-Wallis test for comparing k samples subject to unequal patterns of censorship
11. Evaluation of survival data and two new rank order statistics arising in its consideration
12. Chemotherapy in the treatment of cancer of the ovary
13. Second-effort surgical resection for bulky ovarian cancer
14. Second-look operations in the planned management of advanced ovarian carcinoma
15. Advanced ovarian cancer: Brief intensive combination chemotherapy and second-look operation
16. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer
17. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma
18. A predictive index of cure versus no cure in advanced ovarian carcinoma patients—Replacement of second-look laparotomy as a diagnostic test